Knockdown of LINK-A markedly improved the protein stability of the PLC components and MHC class I (MHC-I) complex and enhanced the infiltration of CD8+ T cells into the tumor tissue, hence sensitizing breast cancer cells to ICI. Here, CD8A is linked to neoplasm.